focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: SulNOx, Marwyn loss widens; Kropz gets new facility

Fri, 28th Oct 2022 21:18

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Tullow Oil PLC - London-based oil and gas exploration company - and Capricorn Energy PLC - Edinburgh-based oil and gas exploration and development company - Confirm that they will no longer proceed with a combination. The Takeover Panel has consented to the withdrawal of Tullow's associated offer. At end of September, Tullow set out plans to terminate its co-operation deal with Capricorn Energy PLC, after Capricorn proposed a merger with NewMed Energy Ltd. Capricorn also withdrew its recommendation for the previously agreed combination with Tullow.

----------

Inspecs Group PLC - Bath, England-based eyewear company - Chief Executive Officer Robin Christian Bjorn Totterman buys 378,376 shares at 52.47 pence each, totalling around GBP198,534.

----------

Kropz PLC - African phosphate developer - Enters into a new bridge loan facility of ZAR126 million, or GBP6.0 million, with its major shareholder, the ARC Fund, to meet immediate cash requirements due to delays in the ramp-up of operations at Kropz Elandsfontein Pty Ltd.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Allots and issues a total of 4.8 million new ordinary shares of 5 pence each in Diurnal. This follows the court sanctioning the scheme in relation to the recommended cash offer by Neurocrine Biosciences Inc.

----------

Upland Resources Ltd - London-based oil and gas company - Pretax loss in the year which ended June 30 narrows to GBP494,295 versus GBP789,892 a year ago. Administrative expenses drop to GBP354,828 from GBP570,676. Registers an intangible asset impairment cost of GBP219,216 in the prior period. Records no revenue in the period, unchanged from a year before.

----------

Umuthi Healthcare Solutions PLC - London-based healthcare firm - Loss from operating activities in the six months to August 31 narrows to GBP6,329 from GBP82,500, year-on-year. Administrative expenses fall to GBP6,329 from GBP82,500. Records no revenue, unchanged from a year before.

----------

ADM Energy PLC - London-based natural resource investor - Raises GBP500,000 net through the issue of 41.7 million new ordinary shares to Tennessee Black Gold at a subscription price of 1.2 pence per share. The shares will represent 14% of its enlarged issued share capital. Says its subscriber has also agreed to provide the company with a loan facility of USD250,000, to be advanced in five monthly instalments of USD50,000 each.

----------

BlueRock Diamonds PLC - Reading-based diamond producer focused on South Africa - In the third quarter of 2022, produces 195,848 tonnes from its Kareevlei diamond mine in South Africa, up 23% versus 159,867t a year before. Sells 5,475 carats, down 21% from 6,887 carats quarter-on-quarter. "In order to adhere to the mining plan there was a significant increase in activity related to stripping, waste mined and movement of stockpiles," CEO Victor Dingle says. Revises its guidance for 2022 and 2023 to reflect the outcome of a high-level review undertaken of the production and mining plan and continued uncertainty over production and grade. Expects to 600,000t to 700,000t processed, down from 620,000t to 670,000t.

----------

Golden Prospect Precious Metals Ltd - investment fund - Pretax loss widens in the six months to June 30 to GBP9.4 million from GBP9.2 million a year ago. Fair value through loss widens to GBP8.9 million from GBP8.8 million. Records no income, unchanged from a year before.

----------

Bidstack Group PLC - London-based in-game advertising platform - Notes recent press commentary regarding a private communication by the company "with certain investors" concerning an email received from Azerion. Says contrary to the press commentary, there is no litigation with Azerion, and the contract with Azerion continues to operate as expected.

----------

SulNOx Group PLC - London-based supplier of fuel conditioners - Pretax loss in the six months to September 30 widens to GBP964,702 versus GBP724,121 a year before, as administrative expenses jump to GBP975,069 from GBP723,718. Revenue triples to GBP74,805 from GBP24,486. Says it is starting to see "significant traction" in the sales of its SulNOxEco Fuel Conditioner product. Says revenue pipeline is strong and diversified by geography and industry.

----------

MAC Alpha Ltd - acquisition vehicle listed on LSE - Records a pretax loss of GBP266,043 in the period from incorporation on October 11 to June 30. Registers administrative expenses of GBP266,043.

----------

Marwyn Acquisition Co III Ltd - acquisition vehicle - Pretax loss in the year to June 30 widens to GBP1.1 million from GBP636,141, year-on-year. Records a GBP254,000 movement in the fair value of warrants. Administrative expenses rise to GBP892,233 versus GBP636,141. Records no revenue, unchanged from a year before. Remains confident in delivering its strategy and creating significant value for its shareholders.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
25 Jul 2018 09:39

IP Group Swings To Loss In First-Half On Reduction In Portfolio Gains

LONDON (Alliance News) - IP Group PLC on Wednesday said it saw a swing to loss in the first half of 2018 despite an improvement in its portfolio valuation.The intellectual property-based to

Read more
18 Jun 2018 16:22

Abcam Appoints Former Celltech CFO As Non-Executive Chairman

LONDON (Alliance News) - Life sciences company Abcam PLC said Monday it has appointed the former chief financial officer of Celtech Group PLC as a non-executive chairman.Peter Allen is a at

Read more
3 Apr 2018 16:19

Diurnal To Raise GBP10.5 Million Via Share Placing (ALLISS)

LONDON (Alliance News) - Diurnal Group PLC said on Tuesday that it intends to raise GBP10.5 million through the placing of different types of shares.The

Read more
20 Mar 2018 18:28

Diurnal Nets GBP500,000 From Broker Option Exercise (ALLISS)

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC on Tuesday said that it has received a letter of notice to exercise the broker option in respect of 263,157 in

Read more
12 Mar 2018 13:51

UPDATE: Diurnal Prepares For First Revenue As Appoints Trial Partner

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC on Monday appointed a clinical trial services provider for its Chronocort treatment, as it posted a widened loss

Read more
12 Mar 2018 10:18

Diurnal Interim Loss Widens On Cost Rise As Prepares For First Revenue

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Monday its interim loss widened amid a rise in research and administrative expenses, as it prepares to its

Read more
12 Mar 2018 05:17

UK Stocks-Factors to watch on March 12

March 12 (Reuters) - Britain's FTSE 100 index is seen opening up 8 points higher at 7,233 on Monday, according to financial bookmakers. * GKN-MELROSE: GKN has struck a deal

Read more
25 Jan 2017 09:31

Diurnal Agrees Two Deals With UDG Healthcare Ahead Of Infacort Launch

Read more
17 Jan 2017 15:43

DIRECTOR DEALINGS: Diurnal Non-Executive Ups Interest

Read more
16 Jan 2017 15:08

Director dealings: Diurnal trio dip in after EMA submission in December

(ShareCast News) - A trio of Diurnal Group directors bought shares in the hormone disease specialist, which remain little higher than the low reached late last year. Chairman Peter Allen bought 40,000 shares at 105p and non-executive directors Sam Williams and John Goddard bought 9,248 each at a pri

Read more
12 Jan 2017 09:04

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

Read more
20 Dec 2016 12:23

Diurnal Submits European Marketing Application For Infacort

Read more
21 Nov 2016 09:32

Diurnal Doses First Testosterone Replacement Therapy Trial Patients

Read more
5 Oct 2016 15:09

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
11 Jul 2016 08:00

Diurnal and IP Group eye 2017 launch for childhood hormonal treatment

(ShareCast News) - Diurnal Group, 45%-owned by university spin-out specialist IP Group, has produced positive clinical trial results for its treatment for a rare hormonal disease in young children. A European Phase III study for AIM-quoted Diurnal's Infacort treatment for paediatric Adrenal Insuffic

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.